PND22 Pharmacoeconomic Assessment of Natalizumab in the Treatment of Multiple Sclerosis
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.781
https://www.valueinhealthjournal.com/article/S1098-3015(12)00846-7/fulltext
Section Title :
Neurological Disorders
Section Order :
266
First Page :
A145
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00846-7&doi=10.1016/j.jval.2012.03.781